Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

EBV latent membrane protein 2A orchestrates p27 kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice

Kamonwan Fish, Richard P. Sora, Samantha J. Schaller, Richard Longnecker, Masato Ikeda

Blood (2017) 130 (23): 2516–2526.

https://doi.org/10.1182/blood-2017-07-796821

Published: 2017

Includes: Supplemental data

Journal Articles

The Syk Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of EBV-Associated Lymphoma

Osman Cen, PhD, Karuppiah Kannan, PhD, Jessica J. Huck, M.A., Jie Yu, M.S., Mengkun Zhang, MD, Leo I Gordon, MD, Richard Longnecker, PhD

Blood (2016) 128 (22): 4179.

https://doi.org/10.1182/blood.V128.22.4179.4179

Published: 2016

Journal Articles

Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma

Kamonwan Fish, Jia Chen, Richard Longnecker

Blood (2014) 123 (4): 530–540.

https://doi.org/10.1182/blood-2013-07-517649

Published: 2014

Includes: Supplemental data

Journal Articles

Off-targeting oft-targeted CD20 in cHL

Leo I. Gordon, Richard Longnecker

Blood (2012) 119 (18): 4095–4096.

https://doi.org/10.1182/blood-2012-03-413146

Published: 2012

Journal Articles

A shared gene expression signature in mouse models of EBV-associated and non–EBV-associated Burkitt lymphoma

Kathryn T. Bieging, Kamonwan Fish, Subbarao Bondada, Richard Longnecker

Blood (2011) 118 (26): 6849–6859.

https://doi.org/10.1182/blood-2011-02-338434

Published: 2011

Includes: Supplemental data

Journal Articles

Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo

Leah J. Anderson, Richard Longnecker

Blood (2009) 113 (1): 108–116.

https://doi.org/10.1182/blood-2008-06-160937

Published: 2009

Journal Articles

Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma

Toni Portis, Patricia Dyck, Richard Longnecker

Blood (2003) 102 (12): 4166–4178.

https://doi.org/10.1182/blood-2003-04-1018

Published: 2003

Includes: Supplemental data

NARROW

EBV latent membrane protein 2A orchestrates p27 kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice

The Syk Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of EBV-Associated Lymphoma

Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma

Off-targeting oft-targeted CD20 in cHL

A shared gene expression signature in mouse models of EBV-associated and non–EBV-associated Burkitt lymphoma

Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo

Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma

Email alerts

ASH Publications

American Society of Hematology

EBV latent membrane protein 2A orchestrates p27 kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice

The Syk Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of EBV-Associated Lymphoma

Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma

Off-targeting oft-targeted CD20 in cHL

A shared gene expression signature in mouse models of EBV-associated and non–EBV-associated Burkitt lymphoma

Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo

Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only